Peginesatide for Anemia in Chronic Hemodialysis Patients
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacodynamics (PD), and
pharmacokinetics (PK) of multiple intravenous doses of peginesatide in participants with
chronic kidney disease (CKD) who are on hemodialysis.